Changes in the normal human breast throughout the menstrual cycle: Relevance to breast carcinogenesis

Endocrine-Related Cancer

Volumn 4, Issue 1, 1997, Pages 23-33

  Anderson, E ^a   Clarke, R B ^a   Howell, A ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; PROGESTERONE;

BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST DEVELOPMENT; CANCER RISK; CELL DIFFERENTIATION; GROWTH REGULATION; HORMONAL REGULATION; HUMAN; MENSTRUAL CYCLE; RECEPTOR DENSITY; REVIEW; SEXUAL MATURATION;

EID: 0030957741     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0040023     Document Type: Review

References (29)

1. van Agthoven T, Timmermans M, Foekens JA, Dorssers LC & Henzen-Logmans SC 1994 Differential expression of estrogen, progesterone and epidermal growth factor receptors in normal, benign and malignant human breast tissues using dual staining immunohistochemistry. American Journal of Pathology 144 1238-1246.
2. Anderson TJ, Ferguson DJP & Raab GM 1982 Cell turnover in the 'resting' human breast: influence of parity, contraceptive pill, age and laterality. British Journal of Cancer 46 376-382.
3. Anderson TJ, Battersby S, King RJ, McPherson K & Going JJ 1989 Oral contraceptive use influences resting breast proliferation. Human Pathology 20 1139-1144.
4. Clarke CL & Sutherland RL 1990 Progestin regulation of cellular proliferation. Endocrine Reviews 11 266-301.
5. Fanger H & Ree HJ 1974 Cyclic changes of human mammary gland epithelium in relation to the menstrual cycle - an ultrastructural study. Cancer 34 574-585.
6. Ferenczy A, Bertrand G & Gelfand MM 1979 Proliferation kinetics of human endometrium during the normal menstrual cycle. American Journal of Obstetrics and Gynecology 133 859-867.
7. Ferguson JE, Schor AM, Howell A & Ferguson MWJ 1990 Tenascin distribution in the normal human breast is altered during the menstrual cycle and in carcinoma. Differentiation 42 199-207.
8. Ferguson JE, Schor AM, Howell A & Ferguson MWJ 1992 Changes in the extracellular matrix of the normal human breast during the menstrual cycle. Cell and Tissue Research 268 167-177.
9. Going JJ, Anderson TJ, Battersby S & MacIntyre CCA 1988 Proliferative and secretory activity in human breast tissue during natural and artificial menstrual cycles. American Journal of Pathology 130 193-204.
10. Gompel A, Martin A, Simon P, Schoevaert D, Plu-Bureau G, Hugol D, Audouin J, Leygue E, True JB & Poitout Ph 1996 Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle. Breast Cancer Research and Treatment 38 227-235.
11. Henderson BE, Ross RK, Judd HL, Krailo MD & Pike MC 1985 Do regular ovulatory cycles increase breast cancer risk? Cancer 56 1206-1208.
12. Kelsey JL & Berkowitz GS 1988 Breast cancer epidemiology. Cancer Research 48 5616-5623.
13. Key TJA & Pike MC 1988 The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. European Journal of Cancer and Clinical Oncology 24 29-43.
14. Laidlaw IJ, Clarke RB, Howell A, Owen AWMC, Potten CS & Anderson E 1995 Proliferation of normal human breast tissue implanted in athymic nude mice is stimulated by estrogen and not progesterone. Endocrinology 136 164-171.
15. Longacre TA & Bartow SA 1986 A correlative morphologic study of human breast and endometrium in the menstrual cycle. American Journal of Surgical Pathology 10 382-393.
16. McManus MJ & Welsch CW 1981 Hormone-induced ductal DNA synthesis of human breast tissues maintained in the athymic nude mouse. Cancer Research 41 3300-3305.
17. McManus MJ & Welsch CW 1984 The effect of estrogen, progesterone, thyroxine, and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice. Cancer 54 1920-1927.
18. Masters JRW, Drife JO & Scarisbrook JJ 1977 Cyclic variation of DNA synthesis in human breast epithelium. Journal of the National Cancer Institute 58 1263-1265.
19. Meyer JS 1977 Cell proliferation in normal human breast ducts, fibroadenomas and other ductal hyperplasia measured by nuclear labelling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones. Human Pathology 8 67-81.
20. Pike MC, Krailo MD, Henderson BE, Casagrande JT & Hoel DG 1983 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature 303 767-770.
21. Pike MC, Daniels JR & Spicer DV 1997 A hormonal contraceptive approach to reducing breast and ovarian cancer risk: an update. Endocrine-Related Cancer 4 125-133.
22. Potten CS, Watson RJ, Williams GT, Tickle S, Roberts SA, Harris M & Howell A 1988 The effect of age and menstrual cycle upon proliferative activity of the normal human breast. British Journal of Cancer 58 163-170.
23. Rebar RW & Yen SSC 1979 Endocrine rhythms in gonadotropins and ovarian steroids with reference to reproductive processes. In Endocrine Rhythms, p 259. Ed DT Krieger. New York: Raven Press.
24. Rostagno P, Caldani C & Lahlou B 1996 Cell cycle expression of steroid receptors determined by image analysis on human breast cancer cell line: A hypothesis on the effects of antiestrogens. Breast Cancer Research and Treatment 37 77-87.
25. Russo J & Russo IH 1997 Role of differentiation in the pathogenesis and prevention of breast cancer. Endocrine-Related Cancer 4 7-21.
26. Sabourin JC, Martin A, Baruch J, Truc JB, Compel A & Poitout P 1994 bcl-2 expression in normal human breast tissue during the menstrual cycle. International Journal of Cancer 59 1-6.
27. Vogel PM, Georgiade NG, Fetter BF, Vogel S & McCarty KS Jr 1981 The correlation of histologic changes in the human breast with the menstrual cycle. American Journal of Pathology 104 23-34.
28. Wellings SR, Jensen HM & Marcum RG 1975 An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. Journal of the National Cancer Institute 55 231-273.
29. Williams G, Andersen E, Howell A, Watson R, Coyne J, Roberts SA & Potten C 1991 Oral contraceptive use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. International Journal of Cancer 48 206-210.